PDF
Summary of National Advisory Committee on Immunization (NACI) Statement of September 1, 2022: Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines
Organization: Public Health Agency of Canada (PHAC)Published: 2022
This document provides summary of the NACI statement of September 1, 2022 on recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines.
Additional Authors: Nima Islam, Marina Salvadori, Matthew C Tunis, Robyn Harrison, Sarah Wilson, and Shelly Deeks
Resource Group:
Implementation Tool
Product Type: Guide
Outbreaks and Pandemics
COVID-19
Vaccine Safety and Development
Vaccine Safety
Sub Topics: Vaccine Safety and Development
Program Planning and Delivery
Program Delivery and Evaluation
Clinics
Product Type: Guide
Category:
Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19,Vaccine Safety and Development,Vaccine Safety,Sub Topics: Vaccine Safety and Development,Program Planning and Delivery,Program Delivery and Evaluation,Clinics Monitoring and SurveillanceOutbreaks and Pandemics
COVID-19
Vaccine Safety and Development
Vaccine Safety
Sub Topics: Vaccine Safety and Development
Program Planning and Delivery
Program Delivery and Evaluation
Clinics
Language:
English
Link
AudioResource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.